A gp130 modulator
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

RCGD 423

Item No. 31420

Technical Information
Formal Name
N-(4-bromophenyl)-4-phenyl-2-thiazolamine
CAS Number
108237-91-8
Molecular Formula
C15H11BrN2S
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: 100 mMEthanol: 100 mM
SMILES
BrC(C=C1)=CC=C1NC2=NC(C3=CC=CC=C3)=CS2
InChi Code
InChI=1S/C15H11BrN2S/c16-12-6-8-13(9-7-12)17-15-18-14(10-19-15)11-4-2-1-3-5-11/h1-10H,(H,17,18)
InChi Key
OUFYYVAASPLOAA-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    RCGD 423 is a modulator of gp130.1 It increases levels of phosphorylated STAT3 and Myc in isolated pig articular chondrocytes (EC50s = 4.5-7.2 µM), effects that can be reversed by the gp130 inhibitor SC144 (Item No. 29714). RCGD 423 reduces cellular apoptosis and hypertrophy induced by bone morphogenic protein 4 (BMP4) in isolated mouse total limb cells and isolated human healthy and osteoarthritic articular chondrocytes. In vivo, RCGD 423 (4 µg/joint) reduces cartilage loss in a rat model of osteochondral injury.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Shkhyan, R., Van Handel, B., Bogdanov, J., et alDrug-induced modulation of gp130 signalling prevents articular cartilage degeneration and promotes repair. Ann. Rheum. Dis. 77(5), 760-769 (2018).